BioMark, who joined as an Operating Partner in 2018, is the founder and CEO of Ampersand portfolio company, Brammer Bio. Previously, Mark founded Gallus BioPharmaceuticals, a premier CDMO delivering clinical and commercial mammalian based biopharmaceuticals which was sold to DPx Holdings B.V. (Patheon) in September 2014. Mark spent 22 years in the UK and USA, running global operations and a pharmaceutical CMO business f ....
Education